These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy. Der Sarkissian SA, Wong XL, Kossard S, Hong A, Sebaratnam DF. Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811 [Abstract] [Full Text] [Related]
4. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Mariani LG, Schmitt IR, Garcia CD, Kiszewski AE. Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627 [No Abstract] [Full Text] [Related]
7. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma. Liu YX, Zhang J, Nie XL, Chen YL, Wang ZY, Xu ZG. Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947 [No Abstract] [Full Text] [Related]
8. Successful treatment of Kaposiform hemangioendothelioma with everolimus. Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K. Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933 [Abstract] [Full Text] [Related]
9. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine. Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, Bueno-Rodríguez I, Ramírez-Villar G, López-Gutierrez JC. Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581 [No Abstract] [Full Text] [Related]
10. Image Gallery: Kaposiform haemangioendothelioma. Moscarella E, Ametrano O, Diplomatico M, De Chiara C, Capasso M, Errico ME, Picciocchi R. Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217 [No Abstract] [Full Text] [Related]
11. Successful treatment of kaposiform lymphangiomatosis with sirolimus. Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S. Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153 [Abstract] [Full Text] [Related]
12. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms. Iacobas I, Simon ML, Amir T, Gribbin CE, McPartland TG, Kaufman MR, Calderwood S, Nosher JL. Clin Imaging; 2015 Jul; 39(3):529-32. PubMed ID: 25662209 [Abstract] [Full Text] [Related]
13. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. Wang Y, Kong L, Sun B, Cui J, Shen W. J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003 [Abstract] [Full Text] [Related]
16. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome. Chan S, Cassarino DS. JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816 [No Abstract] [Full Text] [Related]
17. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence? Ji Y, Chen S, Yang K, Xia C, Peng S. J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141 [Abstract] [Full Text] [Related]